Appraisals - ASAR & FAR

25/07/2019

Appraisal Report: lopinavir / ritonavir (Kaletra) 3557

21/02/2020

Appraisal Report: lisdexamfetamine dimesylate (ElvanseAdult) 2534

01/08/2019

Appraisal Report: linagliptin-metformin (Jentadueto) 2446

25/07/2019

Appraisal Report: levonorgestrel (Kyleena) 3582

21/02/2020

Appraisal Report: ledipasvir sofosbuvir (Harvoni) 1887

25/07/2019

Appraisal Report: lanreotide (Somatuline Autogel) 1988

25/07/2019

Appraisal Report: lacosamide (Vimpat) 3343

28/04/2020

Appraisal Report: ketotifen (Ketofall) 3930

31/07/2019

Appraisal Report: isavuconazole (Cresemba) 2433

25/07/2019

Appraisal Report: ipilimumab (Yervoy) 3604

20/02/2020

Appraisal report: insulin glargine (Abasaglar) 2307

15/07/2020

Appraisal Report: insulin degludec/liraglutide (Xultophy) 2544

31/07/2019

Appraisal Report: insulin degludec (Tresiba) 3158

20/02/2020

Appraisal Report: infliximab (Remsima) 2254

20/02/2020

Appraisal Report: infliximab (Inflectra) 2253

17/05/2021

Appraisal Report: indacaterol (Enerzair Breezhaler) 3141

27/01/2022

Appraisal Report: inclisiran (Leqvio) 3746

20/02/2020

Appraisal report: imatinib (Glivec) 1653

25/07/2019

Appraisal Report: icatibant acetate (Firazyr) 3293

09/07/2020

Appraisal Report: hydroxycarbamide (Xromi) 4264